{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:47:35Z","timestamp":1782859655306,"version":"3.54.5"},"reference-count":36,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,3,18]]},"abstract":"<jats:p>\n            Tavaborole is currently used in the topical treatment of onychomycosis. In this study, we analyzed the\n            <jats:italic>in vitro<\/jats:italic>\n            emergence\/evolution of resistance against tavaborole in\n            <jats:named-content content-type=\"genus-species\">Trichophyton rubrum<\/jats:named-content>\n            .\n          <\/jats:p>","DOI":"10.1128\/aac.02324-20","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T13:33:18Z","timestamp":1611149598000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":11,"title":["<i>In Vitro<\/i>\n            Resistance and Evolution of Resistance to Tavaborole in Trichophyton rubrum"],"prefix":"10.1128","volume":"65","author":[{"given":"Diletta","family":"Mazzantini","sequence":"first","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Celandroni","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Calvigioni","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Lupetti","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6863-1384","authenticated-orcid":true,"given":"Emilia","family":"Ghelardi","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy"},{"name":"Research Center Nutraceuticals and Food for Health-Nutrafood, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16394"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1142189"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.14.76"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.04.010"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/0897190016660487"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1039\/c9md00139e"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20901"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep02475"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0276-7"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2016.1206467"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2016.01.028"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.9b00071"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-008-9110-7"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01108"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000696"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-013-9655-y"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02382-13"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00115-17"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13411"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00442-19"},{"key":"e_1_3_2_22_2","volume-title":"CLSI standard M38","author":"Clinical and Laboratory Standards Institute","year":"2015","unstructured":"Clinical and Laboratory Standards Institute. 2015. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi\u20143rd ed. CLSI standard M38. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"3"},{"key":"e_1_3_2_23_2","unstructured":"Anacor Pharmaceuticals. 2014. FDA approves Kerydin (tavaborole) topical solution for onychomycosis of the toenails. Drugs.com. http:\/\/www.drugs.com\/nda\/tavaborole_131003.html."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","unstructured":"Jinna S Finch J. 2015. Spotlight on tavaborole for the treatment of onychomycosis. Drug Des Devel Ther 9:6185\u20136190. doi:10.2147\/DDDT.S81944.","DOI":"10.2147\/DDDT.S81944"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.3390\/jof3040058"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01632-18"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.7547\/16-154"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2011.08.010"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2003132117"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02058-12"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02940-15"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-016-2738-1"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.1.82-86.2003"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.16.2.157"},{"key":"e_1_3_2_35_2","first-page":"609","article-title":"In vitro nail penetration and antifungal activity of tavaborole, a boron-based pharmaceutical","volume":"14","author":"Coronado D","year":"2015","unstructured":"Coronado D, Merchant T, Chanda S, Zane LT. 2015. In vitro nail penetration and antifungal activity of tavaborole, a boron-based pharmaceutical. J Drugs Dermatol 14:609\u2013614.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_2_36_2","first-page":"6","article-title":"Tavaborole 5% solution: a novel topical treatment for toenail onychomycosis","volume":"20","author":"Gupta G","year":"2015","unstructured":"Gupta G, Foley KA, Gupta AK. 2015. Tavaborole 5% solution: a novel topical treatment for toenail onychomycosis. Skin Therapy Lett 20:6\u20139.","journal-title":"Skin Therapy Lett"},{"key":"e_1_3_2_37_2","first-page":"675","article-title":"In vitro nail penetration of tavaborole topical solution, 5%, through nail polish on ex vivo human fingernails","volume":"14","author":"Vlahovic T","year":"2015","unstructured":"Vlahovic T, MPharm TM, Chanda S, Zane LT, Coronado D. 2015. In vitro nail penetration of tavaborole topical solution, 5%, through nail polish on ex vivo human fingernails. J Drugs Dermatol 14:675\u2013678.","journal-title":"J Drugs Dermatol"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02324-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02324-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:40:52Z","timestamp":1645486852000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02324-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,3,18]]}},"alternative-id":["10.1128\/AAC.02324-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.02324-20","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"2020-11-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02324-20"}}